Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Its poor prognosis is predominantly due to the fact that most patients remain asymptomatic until the disease reaches an advanced stage, alongside the lack of early markers and screening strategies. A better understanding of PDAC risk factors is essential for the identification of groups at high risk in the population. Genome-wide association studies (GWAS) have been a powerful tool for detecting genetic variants associated with complex traits, including pancreatic cancer. By exploiting functional and GWAS data, we investigated the associations between polymorphisms affecting gene function in the pancreas (expression quantitative trait loci, eQTLs) and PDAC risk. In a ...
There is overwhelming evidence that inflammation plays a key role in the pathogenesis of cancer and ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer (PC). It is a r...
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumor with a five‐year survival of less...
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Its poor prognosis is pred...
Purpose There are overwhelming epidemiologic evidences that suggest single nucleotide polymorphis...
Pancreatic ductal adenocarcinoma (PDAC), which represent the 95% of all the pancreatic cancers, is o...
Germline genetic variability might contribute, at least partially, to the survival of pancreatic duc...
International audiencePancreatic ductal adenocarcinoma (PDAC) is a devastating disease progressing a...
Early onset pancreatic cancer (EOPC) is a rare disease with a very high mortality rate. Almost nothi...
Pancreatic ductal adenocarcinoma (PDAC) is a neoplasm characterized by a high mortality rate due to ...
Pancreatic cancer (PC), particularly its most common form, pancreatic ductal adenocarcinoma (PDAC), ...
There is overwhelming evidence that inflammation plays a key role in the pathogenesis of cancer and ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer (PC). It is a r...
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumor with a five‐year survival of less...
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Its poor prognosis is pred...
Purpose There are overwhelming epidemiologic evidences that suggest single nucleotide polymorphis...
Pancreatic ductal adenocarcinoma (PDAC), which represent the 95% of all the pancreatic cancers, is o...
Germline genetic variability might contribute, at least partially, to the survival of pancreatic duc...
International audiencePancreatic ductal adenocarcinoma (PDAC) is a devastating disease progressing a...
Early onset pancreatic cancer (EOPC) is a rare disease with a very high mortality rate. Almost nothi...
Pancreatic ductal adenocarcinoma (PDAC) is a neoplasm characterized by a high mortality rate due to ...
Pancreatic cancer (PC), particularly its most common form, pancreatic ductal adenocarcinoma (PDAC), ...
There is overwhelming evidence that inflammation plays a key role in the pathogenesis of cancer and ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer (PC). It is a r...
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumor with a five‐year survival of less...